Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Kaitlin Annunzio DO

Kaitlin Annunzio DO profile photo picture

Assistant Professor

Institution: Medical College of Wisconsin
Department: Medicine
Division: Medicine Hematology Oncology

View Curriculum Vitae

Publications (24)

  • Sequencing CAR-Ts in Relapsed DLBCL: Is More Always Better? (Annunzio K, Shah NN) Transplant Cell Ther 2025 Nov;31(11):849-850 PMID: 41176372 SCOPUS ID: 2-s2.0-105020044401 11/02/2025    
  • Outcomes of bispecific antibodies after CAR T-cell failure for large B-cell lymphoma: results from the ABC consortium. (Melody M, Grover N, Franco S, Romancik J, Cortese M, Moyo TK, Bhansali RS, Ollila T, Kenkre V, Fitzgerald L, Hess B, Matasar M, Shouse G, Annunzio K, Herr MM, Davis JA, Jesme C, Pelcovits A, Moreira J, Ma S, Winter JN, Lin A, Danilov A, Roy I, Barta SK, Gordon LI, Stephens D, Cohen JB, Epperla N, Karmali R) Blood Adv 2026 Jan 13;10(1):228-232 PMID: 41124653 PMCID: PMC12811448 SCOPUS ID: 2-s2.0-105026536850 10/22/2025       3 Citations
  • Impact of extranodal involvement at CAR T-cell therapy on outcomes in patients with relapsed or refractory large B-cell lymphoma-Results from a multicenter cohort study. (St-Pierre F, Bhatta S, Doukas PG, Jenkin M, Annunzio K, Rojek AE, Gibson A, Tiger YK, McCall B, Alhamad K, Hansen A, Alderuccio JP, Adewale O, Patel K, Trabolsi A, Lossos IS, Fitzgerald L, Ollila TA, Matasar MJ, Kline J, Karmali R, Epperla N) Blood Cancer J 2025 Jun 21;15(1):110 PMID: 40544154 PMCID: PMC12182562 SCOPUS ID: 2-s2.0-105008531660 06/22/2025       6 Citations
  • Outcomes of follicular lymphoma with leukemic phase in the modern era: results from a large multicenter study. (Trabolsi A, Han S, Epperla N, Annunzio K, Baidoun F, Alhaj Moustafa M, Morgenstern-Kaplan D, Doukas P, St-Pierre F, McCall B, Fitzgerald L, Sandoval-Sus J, Dalal S, Reis IM, Chapman-Fredricks JR, Kim SH, Au C, Otto NB, Alhamad K, Ollila T, Karmali R, Shouse G, Lossos IS, Alderuccio JP) Blood Neoplasia 2025 Feb;2(1):100063 PMID: 40454403 PMCID: PMC12082143 SCOPUS ID: 2-s2.0-105013866358 06/02/2025    
  • Impact of diagnosis to treatment interval on outcomes in patients with newly diagnosed marginal zone lymphoma - a US multisite study. (Epperla N, Shouse G, Grover NS, Torka P, Annunzio K, Watkins M, Anampa-Guzmán A, Christian B, Thomas C, Barta SK, Geethakumari PR, Karmali R, Bartlett NL, Olszewski AJ) Exp Hematol Oncol 2025 May 14;14(1):73 PMID: 40369604 PMCID: PMC12079943 SCOPUS ID: 2-s2.0-105005102075 05/15/2025       1 Citation
  • Impact of Age on Biology, Presentation and Outcomes in Marginal Zone Lymphoma: Results From a Multicenter Cohort Study. (Torka P, Grover NS, Voorhees TJ, Karmali R, Annunzio K, Watkins MP, Anampa-Guzmán A, Reves H, Tavakkoli M, Christian B, Thomas C, Barta SK, Geethakumari PR, Bartlett NL, Shouse G, Olszewski AJ, Epperla N) Hematol Oncol 2025 May;43(3):e70087 PMID: 40260947 PMCID: PMC12013245 SCOPUS ID: 2-s2.0-105003179311 04/22/2025       2 Citations
  • Chimeric antigen receptor T cell therapy in octogenarians with B cell lymphoma: a real-world US multicenter collaborative study. (Kharfan-Dabaja MA, Mohty R, Easwar N, Johnston P, Iqbal M, Epperla N, Yared J, Ahmed N, Hamadani M, Beitinjaneh A, Narkhede M, Jagadeesh D, Ramakrishnan Geethakumari P, Dholaria B, Gergis U, Munoz J, Sandoval-Sus J, Locke FL, Fein J, Khurana A, Ayala E, Annunzio K, Rapoport AP, Lutfi F, Akhtar OS, Lekakis L, Mehta A, Oluwole OO, Logue J, Jain MD, Shore T, Durani U, Alhaj Moustafa M, McGuirk J, Lin Y, Yamshon S, Chavez JC) Bone Marrow Transplant 2025 May;60(5):632-639 PMID: 40025178 SCOPUS ID: 2-s2.0-85219057986 03/03/2025       13 Citations
  • Impact of circulating lymphoma cells at diagnosis on outcomes in patients with newly diagnosed de novo diffuse large B-cell lymphoma. (Chowdhury SM, Bhatta S, Voorhees TJ, Annunzio K, Bond DA, Sawalha Y, Sigmund A, Hanel W, Sehgal L, Alinari L, Baiocchi R, Maddocks K, Christian B, Jones D, Epperla N) J Hematol Oncol 2025 Jan 05;18(1):4 PMID: 39757235 PMCID: PMC11702192 SCOPUS ID: 2-s2.0-85214091977 01/06/2025       2 Citations
  • Loncastuximab in high-risk and heavily pretreated relapsed/refractory diffuse large B-cell lymphoma: a realworld analysis from 21 US centers. (Zelikson V, Gurumurthi A, Sawalha Y, Annunzio K, Saha A, Dong N, Qualls D, Amoozgar B, Kahl B, Baird J, Challa P, Huntington SF, Santos J, Bair S, Narkhede M, Li S, Frosch Z, Ho C, Smith SD, Winter A, Landsburg D, Furqan F, Hamadani M, Baird K, Romancik J, Alharthy H, Law J, Bojanini L, Advani R, Hu B, Johnson PC, Grover NS, Merril M, Crombie JL, Shafagati N, Sterling C, Nastoupil LJ, Epperla N, Ayers EC) Haematologica 2025 Mar 01;110(3):706-714 PMID: 39540227 PMCID: PMC11873705 SCOPUS ID: 2-s2.0-86000179000 11/14/2024       9 Citations
  • Evaluation of Ki-67 expression and large cell content as prognostic markers in MZL: a multicenter cohort study. (Grover NS, Annunzio K, Watkins M, Torka P, Karmali R, Anampa-Guzmán A, Oh TS, Reves H, Tavakkoli M, Hansinger E, Christian B, Thomas C, Barta SK, Geethakumari PR, Bartlett NL, Shouse G, Olszewski AJ, Epperla N) Blood Cancer J 2024 Oct 18;14(1):182 PMID: 39424808 PMCID: PMC11489653 SCOPUS ID: 2-s2.0-85206819208 10/19/2024       12 Citations
  • Prognostic relevance of circulating lymphoma cells at diagnosis in newly diagnosed follicular lymphoma patients. (Annunzio K, Bhatta S, Hanel W, Zhao Q, Owen M, Rosen H, Voorhees TJ, Bond DA, Sawalha Y, Sigmund AM, Alinari L, Baiocchi RA, Maddocks KJ, Jones D, Christian B, Epperla N) Hematol Oncol 2024 May;42(3):e3278 PMID: 38726682 SCOPUS ID: 2-s2.0-85192711022 05/10/2024       1 Citation
  • Impact of race and social determinants of health on outcomes in patients with aggressive B-cell NHL treated with CAR-T therapy. (Karmali R, Machhi R, Epperla N, Shouse G, Romancik J, Moyo TK, Kenkre V, Ollila TA, Fitzgerald L, Hess B, David K, Roy I, Zurko J, Chowdhury SM, Annunzio K, Ferdman R, Bhansali RS, Harris EI, Liu J, Nizamuddin I, Ma S, Moreira J, Winter J, Pro B, Stephens DM, Danilov A, Shah NN, Cohen JB, Barta SK, Torka P, Gordon LI) Blood Adv 2024 May 28;8(10):2592-2599 PMID: 38531057 PMCID: PMC11145749 SCOPUS ID: 2-s2.0-85195045599 03/26/2024       25 Citations
  • Outcomes of marginal zone lymphoma treated with ibrutinib in the first-line setting in the United States: a real-world analysis. (Epperla N, Zhao Q, Moyo T, Watkins MP, Tavakkoli M, Bello C, Torka P, Reddy N, Thomas C, Annunzio K, Christian B, Barta SK, Shouse G, Olszewski AJ, Bartlett NL) Blood Adv 2024 Feb 13;8(3):549-552 PMID: 38091577 PMCID: PMC10835265 SCOPUS ID: 2-s2.0-85185395343 12/13/2023       2 Citations
  • Single-center study of outcomes of patients with hairy cell leukemia who contracted SARS-CoV-2. (Annunzio K, Ozga M, Huang Y, Anghelina M, Bhat SA, Blachly JS, Grever MR, Lozanski G, Neal J, Shindiapina P, Rogers KA) EJHaem 2023 Nov;4(4):1200-1202 PMID: 38024604 PMCID: PMC10660372 11/29/2023    
  • Efficacy of CD19 directed therapies in patients with relapsed or refractory large b-cell lymphoma relapsing after CD19 directed chimeric antigen receptor T-cell therapy. (Iqbal M, Jagadeesh D, Chavez J, Khurana A, Rosenthal A, Craver E, Epperla N, Li Z, Isufi I, Awan FT, Dholaria BR, Maakaron JE, Sandoval-Sus JD, Mishra R, Saha A, Annunzio K, Bhaskar ST, Sumransub N, Fijalka A, Ivanov SA, Lin Y, Kharfan-Dabaja MA) Bone Marrow Transplant 2024 Feb;59(2):211-216 PMID: 37973893 SCOPUS ID: 2-s2.0-85176747640 11/17/2023       15 Citations
  • Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study. (Epperla N, Feng L, Shah NN, Fitzgerald L, Shah H, Stephens DM, Lee CJ, Ollila T, Shouse G, Danilov AV, David KA, Torka P, Hashmi H, Hess B, Barta SK, Romancik JT, Cohen JB, Annunzio K, Kittai AS, Reneau J, Zurko J, Nizamuddin IA, Winter JN, Gordon LI, Ma S, Patel R, Nastoupil L, Ahmed S, Karmali R) J Hematol Oncol 2023 Nov 09;16(1):111 PMID: 37946255 PMCID: PMC10633964 SCOPUS ID: 2-s2.0-85176094636 11/10/2023       55 Citations
  • Impact of circulating lymphoma cells at diagnosis on outcomes in patients with marginal zone lymphoma: a multicenter cohort study. (Annunzio K, Grover NS, Welkie RL, Torka P, Watkins MP, Anampa-Guzmán A, Tavakkoli M, Oh TS, Reves H, Jones D, Hanel W, Christian B, Ramakrishnan Geethakumari P, Karmali R, Barta SK, Bartlett NL, Olszewski AJ, Epperla N) Blood Adv 2023 Nov 28;7(22):6839-6843 PMID: 37792806 PMCID: PMC10679805 SCOPUS ID: 2-s2.0-85178322061 10/04/2023       4 Citations
  • Impact of circulating lymphoma cells at diagnosis on outcomes in patients with Waldenstrom macroglobulinemia. (Nalin A, Zhao Q, Voorhees T, Bond D, Sawalha Y, Hanel W, Sigmund A, Annunzio K, Alinari L, Baiocchi R, Maddocks K, Jones D, Christian B, Epperla N) Front Oncol 2023;13:1264387 PMID: 37781209 PMCID: PMC10533994 SCOPUS ID: 2-s2.0-85172992886 10/02/2023       2 Citations
  • Impact of cumulative dose of brentuximab vedotin on outcomes of frontline therapy for advanced-stage Hodgkin lymphoma. (Steiner RE, Hwang SR, Khurana A, Habermann TM, Epperla N, Annunzio K, Allen PB, Baird K, Paulino D, Alderuccio JP, Lossos IS, David K, Evens AM, Pandya K, Bair SM, Kamdar M, Ba Aqeel S, Torka P, Lynch R, Smith S, Feng L, Noorani M, Ahmed S, Nair R, Vega F, Wu S, Fang P, Pinnix CC, Gunther JR, Dabaja BS, Lee HJ) Blood Adv 2023 Dec 26;7(24):7485-7493 PMID: 37603594 PMCID: PMC10758726 SCOPUS ID: 2-s2.0-85181001218 08/21/2023       10 Citations
  • Brentuximab vedotin plus AVD for Hodgkin lymphoma: incidence and management of peripheral neuropathy in a multisite cohort. (Bowers JT, Anna J, Bair SM, Annunzio K, Epperla N, Pullukkara JJ, Gaballa S, Spinner MA, Li S, Messmer MR, Nguyen J, Ayers EC, Wagner CB, Hu B, Di M, Huntington SF, Furqan F, Shah NN, Chen C, Ballard HJ, Hughes ME, Chong EA, Nasta SD, Barta SK, Landsburg DJ, Svoboda J) Blood Adv 2023 Nov 14;7(21):6630-6638 PMID: 37595053 PMCID: PMC10628810 SCOPUS ID: 2-s2.0-85177236811 08/18/2023       14 Citations
  • Impact of detectable monoclonal protein at diagnosis on outcomes in marginal zone lymphoma: a multicenter cohort study. (Epperla N, Zhao Q, Karmali R, Torka P, Shea L, Oh TS, Anampa-Guzmán A, Reves H, Tavakkoli M, Greenwell IB, Hansinger E, Umyarova E, Annunzio K, Sawalha Y, Christian B, Thomas C, Barta SK, Geethakumari PR, Bartlett NL, Grover NS, Olszewski AJ) Blood Adv 2023 Sep 12;7(17):5038-5046 PMID: 37315169 PMCID: PMC10471932 SCOPUS ID: 2-s2.0-85171689397 06/14/2023       16 Citations
  • Impact of early relapse within 24 months after first-line systemic therapy (POD24) on outcomes in patients with marginal zone lymphoma: A US multisite study. (Epperla N, Welkie RL, Torka P, Shouse G, Karmali R, Shea L, Anampa-Guzmán A, Oh TS, Reaves H, Tavakkoli M, Lindsey K, Greenwell IB, Hansinger E, Thomas C, Chowdhury SM, Annunzio K, Christian B, Barta SK, Geethakumari PR, Bartlett NL, Herrera AF, Grover NS, Olszewski AJ) J Hematol Oncol 2023 May 08;16(1):49 PMID: 37158890 PMCID: PMC10165748 SCOPUS ID: 2-s2.0-85158129520 05/09/2023       20 Citations
  • Treatment of primary mediastinal B-cell lymphoma with dose-adjusted REPOCH during pregnancy. (Annunzio K, Cackovic M, Bond D, Sawalha Y, Voorhees TJ, Hanel W, Alinari L, Baiocchi R, Reneau J, Brammer J, Maddocks K, Christian B, Epperla N) Blood Adv 2023 May 23;7(10):2241-2244 PMID: 36287222 PMCID: PMC10196908 SCOPUS ID: 2-s2.0-85163466480 10/27/2022       2 Citations
  • Pediatric Bronchogenic Cysts: A Case Series of Six Patients Highlighting Diagnosis and Management. (Cohn JE, Rethy K, Prasad R, Mae Pascasio J, Annunzio K, Zwillenberg S) J Invest Surg 2020 Jul;33(6):568-573 PMID: 30430886 SCOPUS ID: 2-s2.0-85057544565 11/16/2018       24 Citations
    • Last update: 03/10/2026